ICCC vs LH · rev $17.5M vs P/E 23, rev $7.27B
ImmuCell Corporation (ICCC) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
ICCC currently screens at market cap $58.9M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the ICCC and LH stock pages for the full models.
Not investment advice.